{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:10:05Z","timestamp":1774408205509,"version":"3.50.1"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>This article has been retracted. Please see: https:\/\/doi.org\/10.1093\/ejendo\/lvaf049<\/jats:p>","DOI":"10.1093\/ejendo\/lvae107","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T23:15:43Z","timestamp":1724368543000},"page":"300-311","source":"Crossref","is-referenced-by-count":7,"title":["Retracted: Conventional steroids vs. dual-release hydrocortisone on metabolic, cardiovascular, and bone outcomes in adrenal insufficiency: a 10-year study"],"prefix":"10.1093","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8088-4947","authenticated-orcid":false,"given":"Valentina","family":"Guarnotta","sequence":"first","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Section of Endocrinology, University of Palermo , Piazza delle Cliniche 2, 90127 Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Di Stefano","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Section of Endocrinology, University of Palermo , Piazza delle Cliniche 2, 90127 Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2304-6007","authenticated-orcid":false,"given":"Laura","family":"Tomasello","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Section of Endocrinology, University of Palermo , Piazza delle Cliniche 2, 90127 Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Maniscalco","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo , Via del Vespro 133, 90127 Palermo ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6052-8438","authenticated-orcid":false,"given":"Giuseppe","family":"Pizzolanti","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Section of Endocrinology, University of Palermo , Piazza delle Cliniche 2, 90127 Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Arnaldi","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Section of Endocrinology, University of Palermo , Piazza delle Cliniche 2, 90127 Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Giordano","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Section of Endocrinology, University of Palermo , Piazza delle Cliniche 2, 90127 Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"issue":"10274","key":"2024093003555273100_lvae107-B1","first-page":"613","article-title":"Adrenal insufficiency","volume":"397","author":"Husebye","year":"2021","journal-title":"Lancet Rheumatol."},{"issue":"3","key":"2024093003555273100_lvae107-B2","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s12020-021-02649-6","article-title":"Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis","volume":"71","author":"Nowotny","year":"2021","journal-title":"Endocrine"},{"issue":"1","key":"2024093003555273100_lvae107-B3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/cen.13609","article-title":"Mortality data from the European Adrenal Insufficiency Registry\u2014patient characterization and associations","volume":"89","author":"Quinkler","year":"2018","journal-title":"Clin Endocrinol"},{"issue":"7","key":"2024093003555273100_lvae107-B4","doi-asserted-by":"crossref","first-page":"e2759","DOI":"10.1210\/clinem\/dgab096","article-title":"Increased mortality risk in patients with primary and secondary adrenal insufficiency","volume":"106","author":"Ngaosuwan","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2024093003555273100_lvae107-B5","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1210\/jc.2006-0076","article-title":"Premature mortality in patients with Addison's disease: a population-based study","volume":"91","author":"Bergthorsdottir","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024093003555273100_lvae107-B6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1530\/EJE-08-0550","article-title":"Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death","volume":"160","author":"Erichsen","year":"2009","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"2024093003555273100_lvae107-B7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1530\/EJE-16-0657","article-title":"Mortality in patients with diabetes mellitus and Addison's disease: a nationwide, matched, observational cohort study","volume":"176","author":"Chantzichristos","year":"2017","journal-title":"Eur J Endocrinol."},{"issue":"8710","key":"2024093003555273100_lvae107-B8","first-page":"285","article-title":"Premature mortality due to cardiovascular disease in hypopituitarism","volume":"336","author":"Ros\u00e9n","year":"1990","journal-title":"Lancet Rheumatol."},{"issue":"3","key":"2024093003555273100_lvae107-B9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1210\/er.2009-0033","article-title":"Mortality in patients with pituitary disease","volume":"31","author":"Sherlock","year":"2010","journal-title":"Endocr Rev"},{"issue":"11","key":"2024093003555273100_lvae107-B10","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/BF03345773","article-title":"Metabolic and cardiovascular profile in patients with Addison's disease under conventional glucocorticoid replacement","volume":"32","author":"Giordano","year":"2009","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"2024093003555273100_lvae107-B11","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2006-0524","article-title":"The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients","volume":"91","author":"Filipsson","year":"2006","journal-title":"J Clin EndocrinolMetab"},{"issue":"1","key":"2024093003555273100_lvae107-B12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/cen.12603","article-title":"Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy","volume":"82","author":"Johannsson","year":"2015","journal-title":"Clin Endocrinol"},{"issue":"3","key":"2024093003555273100_lvae107-B13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11102-008-0126-2","article-title":"Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study","volume":"11","author":"Danilowicz","year":"2008","journal-title":"Pituitary"},{"issue":"4","key":"2024093003555273100_lvae107-B14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1530\/EJE-15-1096","article-title":"Reduction in daily hydrocortisone dose improves bone health in primary adrenal insufficiency","volume":"174","author":"Schulz","year":"2016","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2024093003555273100_lvae107-B15","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1530\/EJE-15-1187","article-title":"Low-dose hydrocortisone replacement is associated with improved arterial stiffness index and blood pressure dynamics in severely adrenocorticotrophin-deficient hypopituitary male patients","volume":"174","author":"Behan","year":"2016","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"2024093003555273100_lvae107-B16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1530\/EJE-15-1212","article-title":"Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study","volume":"175","author":"Johannsson","year":"2016","journal-title":"Eur J Endocrinol."},{"issue":"7","key":"2024093003555273100_lvae107-B17","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1530\/EC-19-0176","article-title":"Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency","volume":"8","author":"Guarnotta","year":"2019","journal-title":"Endocr Connect."},{"key":"2024093003555273100_lvae107-B18","doi-asserted-by":"crossref","first-page":"204201881987116","DOI":"10.1177\/2042018819871169","article-title":"Dual-release hydrocortisone improves hepatic steatosis in patients with secondary adrenal insufficiency: a real-life study","volume":"10","author":"Guarnotta","year":"2019","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"1","key":"2024093003555273100_lvae107-B19","doi-asserted-by":"crossref","first-page":"13280","DOI":"10.1038\/s41598-022-13506-5","article-title":"Long-term outcomes of conventional and novel steroid replacement therapy on bone health in primary adrenal insufficiency","volume":"12","author":"Guarnotta","year":"2022","journal-title":"Sci Rep"},{"issue":"3","key":"2024093003555273100_lvae107-B20","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s12020-017-1512-1","article-title":"Bone safety of dual-release hydrocortisone in patients with hypopituitarism","volume":"60","author":"Frara","year":"2018","journal-title":"Endocrine"},{"issue":"2","key":"2024093003555273100_lvae107-B21","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2024093003555273100_lvae107-B22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1503\/cmaj.050748","article-title":"Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study","volume":"174","author":"Simpson","year":"2006","journal-title":"CMAJ"},{"issue":"12","key":"2024093003555273100_lvae107-B23","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH guidelines for the management of arterial hypertension the Task Force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens."},{"issue":"1","key":"2024093003555273100_lvae107-B24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12020-021-02806-x","article-title":"DXA parameters, Trabecular Bone Score (TBS) and Bone Mineral Density (BMD), in fracture risk prediction in endocrine-mediated secondary osteoporosis","volume":"74","author":"Shevroja","year":"2021","journal-title":"Endocrine"},{"issue":"3","key":"2024093003555273100_lvae107-B25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S2213-8587(17)30398-4","article-title":"Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial","volume":"6","author":"Isidori","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"2024093003555273100_lvae107-B26","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1055\/s-0033-1351259","article-title":"Increased cardiovascular risk in South African patients with Addison's disease","volume":"45","author":"Ross","year":"2013","journal-title":"Horm Metab Res"},{"issue":"Suppl 1","key":"2024093003555273100_lvae107-B27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000314213","article-title":"Pathophysiology of dyslipidemia in Cushing's syndrome","volume":"92","author":"Arnaldi","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"5","key":"2024093003555273100_lvae107-B28","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1530\/EJE-07-0455","article-title":"Glucocorticoids and cardiovascular disease","volume":"157","author":"Walker","year":"2007","journal-title":"Eur J Endocrinol."},{"issue":"3","key":"2024093003555273100_lvae107-B29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/metabo6030024","article-title":"Impact of glucocorticoid excess on glucose tolerance: clinical and preclinical evidence","volume":"6","author":"Pasieka","year":"2016","journal-title":"Metabolites"},{"issue":"9","key":"2024093003555273100_lvae107-B30","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41574-022-00683-6","article-title":"Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions","volume":"18","author":"Li","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"2024093003555273100_lvae107-B31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1677\/JOE-08-0054","article-title":"Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome","volume":"197","author":"Macfarlane","year":"2008","journal-title":"J Endocrinol."},{"issue":"11","key":"2024093003555273100_lvae107-B32","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1210\/jc.2017-01324","article-title":"Visceral fat and novel biomarkers of cardiovascular disease in patients with Addison's disease: a case-control study","volume":"102","author":"Bergthorsdottir","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2024093003555273100_lvae107-B33","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.3390\/jpm12111829","article-title":"Impact of glucocorticoids on cardiovascular system\u2014the yin yang effect","volume":"12","author":"Kelley","year":"2022","journal-title":"J Pers Med"},{"issue":"1","key":"2024093003555273100_lvae107-B34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-2265.2012.04352.x","article-title":"A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency","volume":"77","author":"Ekman","year":"2012","journal-title":"Clin Endocrinol"},{"issue":"1","key":"2024093003555273100_lvae107-B35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/hrt.67.1.92","article-title":"Myocardial dysfunction in treated adult hypopituitarism: a possible explanation for increased cardiovascular mortality","volume":"67","author":"Shahi","year":"1992","journal-title":"Br Heart J"},{"issue":"5","key":"2024093003555273100_lvae107-B36","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0002-9343(83)91074-4","article-title":"Cardiac failure in Addison's disease","volume":"74","author":"Knowlton","year":"1983","journal-title":"Am J Med"},{"issue":"9","key":"2024093003555273100_lvae107-B37","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.4158\/EP161262.OR","article-title":"Cardiac structural and functional abnormalities in females with untreated hypopituitarism due to Sheehan syndrome: response to hormone replacement therapy","volume":"22","author":"Laway","year":"2016","journal-title":"Endocr Pract."},{"issue":"2","key":"2024093003555273100_lvae107-B38","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s12020-020-02458-3","article-title":"Patients with adrenal insufficiency have cardiovascular features associated with hypovolemia","volume":"70","author":"Esposito","year":"2020","journal-title":"Endocrine"},{"issue":"6","key":"2024093003555273100_lvae107-B39","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1210\/jc.2013-4305","article-title":"Acute effect of increasing glucocorticoid replacement dose on cardiovascular risk and insulin sensitivity in patients with adrenocorticotrophin deficiency","volume":"99","author":"Petersons","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024093003555273100_lvae107-B40","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/HYPERTENSIONAHA.118.12114","article-title":"High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population","volume":"73","author":"Cuspidi","year":"2019","journal-title":"Hypertension"},{"issue":"2","key":"2024093003555273100_lvae107-B41","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s40618-020-01309-2","article-title":"Micro- and macrovascular function in patients suffering from primary adrenal insufficiency: a cross-sectional case\u2013control study","volume":"44","author":"M\u00fcller","year":"2021","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2024093003555273100_lvae107-B42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/EJE-09-0621","article-title":"Cardiac dysfunction is reversed upon successful treatment of Cushing's syndrome","volume":"162","author":"Pereira","year":"2010","journal-title":"Eur J Endocrinol."},{"issue":"8","key":"2024093003555273100_lvae107-B43","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s40618-023-02295-x","article-title":"Epicardial and pericoronary adipose tissue and coronary plaque burden in patients with Cushing's syndrome: a propensity score-matched study","volume":"47","author":"Wang","year":"2024","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"2024093003555273100_lvae107-B44","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1055\/s-2006-944545","article-title":"Patients with Cushing's syndrome have increased intimal media thickness at different vascular levels: comparison with a population matched for similar cardiovascular risk factors","volume":"38","author":"Albiger","year":"2006","journal-title":"Horm Metab Res"},{"issue":"4","key":"2024093003555273100_lvae107-B45","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1365-2265.2006.02473.x","article-title":"Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements","volume":"64","author":"Arlt","year":"2006","journal-title":"Clin Endocrinol"},{"key":"2024093003555273100_lvae107-B46","doi-asserted-by":"crossref","first-page":"996157","DOI":"10.3389\/fendo.2022.996157","article-title":"Trabecular bone score and sclerostin concentrations in patients with primary adrenal insufficiency","volume":"13","author":"Zdrojowy-We\u0142na","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2024093003555273100_lvae107-B47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2796.2011.02352.x","article-title":"Risk of hip fracture in Addison's disease: a population-based cohort study: Addison's disease and fractures","volume":"270","author":"Bj\u00f6rnsdottir","year":"2011","journal-title":"J Intern Med."},{"issue":"6","key":"2024093003555273100_lvae107-B48","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1530\/EJE-08-0880","article-title":"Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone","volume":"160","author":"L\u00f8v\u00e5s","year":"2009","journal-title":"Eur J Endocrinol."},{"issue":"3","key":"2024093003555273100_lvae107-B49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2478\/enr-2022-0022","article-title":"Impact of hydrocortisone replacement on bone mineral density and bone turnover markers in patients with primary adrenal insufficiency","volume":"56","author":"Yazidi","year":"2022","journal-title":"Endocr Regul."},{"key":"2024093003555273100_lvae107-B50","doi-asserted-by":"crossref","first-page":"1234237","DOI":"10.3389\/fendo.2023.1234237","article-title":"Bone safety of dual-release hydrocortisone in patients with autoimmune primary adrenal insufficiency","volume":"14","author":"Bioletto","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2024093003555273100_lvae107-B51","doi-asserted-by":"crossref","first-page":"bvad151","DOI":"10.1210\/jendso\/bvad151","article-title":"Effects of dual-release hydrocortisone on bone metabolism in primary and secondary adrenal insufficiency: a 6-year study","volume":"8","author":"Hasenmajer","year":"2023","journal-title":"J Endocr Soc."}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvae107\/58890442\/lvae107.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/191\/3\/300\/59376390\/lvae107.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/191\/3\/300\/59376390\/lvae107.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T10:47:02Z","timestamp":1742381222000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/191\/3\/300\/7738837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,8,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvae107","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,8,22]]}}}